.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Federal Trade Commission
Colorcon
QuintilesIMS
Teva
Covington
UBS
Chinese Patent Office
Merck
Express Scripts

Generated: November 20, 2017

DrugPatentWatch Database Preview

VELOSULIN BR Drug Profile

« Back to Dashboard

What is the patent landscape for Velosulin Br, and when can generic versions of Velosulin Br launch?

Velosulin Br is a drug marketed by Novo Nordisk Inc and is included in two NDAs.

The generic ingredient in VELOSULIN BR is insulin recombinant purified human. There are thirty-eight drug master file entries for this compound. Additional details are available on the insulin recombinant purified human profile page.

Summary for VELOSULIN BR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novo Nordisk Inc
VELOSULIN BR
insulin recombinant human
INJECTABLE;INJECTION021028-001Jul 19, 1999DISCNNoNo► Subscribe► Subscribe► Subscribe
Novo Nordisk Inc
VELOSULIN BR HUMAN
insulin recombinant purified human
INJECTABLE;INJECTION019450-001May 30, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Chubb
Express Scripts
Harvard Business School
Citi
Fuji
Queensland Health
Covington
Daiichi Sankyo
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot